Critical illness polyneuropathy;Critical-illness-polyneuropathie

Aktuelle Neurologie

Volumn 32, Issue 4, 2005, Pages 202-207

  Hund, Ernst ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTIFICIAL VENTILATION; CRITICAL ILLNESS; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; ELECTROPHYSIOLOGY; HUMAN; INTENSIVE CARE UNIT; MUSCLE ATROPHY; MUSCLE BIOPSY; MUSCLE WEAKNESS; MYOPATHY; NEUROLOGIC DISEASE; POLYNEUROPATHY; PROGNOSIS; QUALITY OF LIFE; REHABILITATION; REVIEW; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 20444377311     PISSN: 03024350     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2004-834705     Document Type: Review

References (59)

1. Witt NJ, Zochodne DW, Bolton CF et al. Peripheral nerve function in sepsis and multiple organ failure. Chest 1991; 99: 176-184
2. Berek K, Margreiter J, Willeit J et al. Polyneuropathies in critically ill patients: a prospective evaluation. Intensive Care Med 1996; 22: 849-855
3. Hund E, Genzwürker H, Böhrer H et al. Predominant involvement of motor fibres in patients with critical illness polyneuropathy. Br J Anaesthesia 1997; 78: 274-278
4. Mook WNKA van, Hulsewe-Evers RPMG. Critical illness polyneuropathy. Curr Opin Crit Care 2002; 8: 302-310
5. Letter M-ACJ De, Schmitz PIM, Visser LH et al. Risk factors for the development of polyneuropathy and myopathy in critically ill patients. Crit Care Med 2001; 29: 2281-2286
6. Tabarki B, Coffinieres A, Bergh P van den et al. Critical illness neuromuscular disease: clinical, electrophysiological, and prognostic aspects. Arch Dis Child 2002; 86: 103-107
7. Hund E, Fogel W, Krieger D et al. Critical illness polyneuropathy: clinical findings and outcomes of a frequent cause of neuromuscular weaning failure. Crit Care Med 1996; 24: 1328-1333
8. Jonghe B De, Bastuji-Garin S, Sharshar T et al. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med 2004; 30: 1117-1121
9. Hughes M, Grant IS, Biccard B et al. Suxamethonium and critical illness polyneuropathy. Anaesth Intensive Care 1999; 27: 636-638
10. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000; 26, suppl 1: S64-S74
11. Latronico N, Rasulo FA, Recupero D et al. Acute quadriplegia with delayed onset and rapid recovery. Case report. J Neurosurg 1998; 88: 769-772
12. Bolton CF. Sepsis and the systemic inflammatory response syndrome: neuromuscular manifestations. Crit Care Med 1996; 24: 1408-1416
13. Hinshaw LB. Sepsis/septic shock: participation of the microcirculation: an abbreviated review. Crit Care Med 1996; 24: 1072-1078
14. Hund E, Herkert M, Becker C-M et al. A humoral neurotoxic factor in sera of patients with critical illness polyneuropathy (abstract). Ann Neurol 1996; 40: 539
15. Waldhausen E, Keser G. Lähmungen durch Kohlenhydrate unter der Intensivtherapie. Anaesthesist 1991; 40: 332-338
16. Bolton CF, Young GB. Critical illness polyneuropathy due to parenteral nutrition [letter]. Intensive Care Med 1997; 23: 924-925
17. Berghe G van den, Wouters P, Weekers F et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367
18. Berghe G van den, Wouters PJ, Bouillon R et al. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31: 359-366
19. Mesotten D, Swinnen JV, Vanderhoydonc F et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 2004; 89:219-226
20. Hansen TK, Thiel S, Wouters PJ et al. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88: 1082-1088
21. Mesotten D, Wouters PJ, Peeters RP et al. Regulation of the somatotropic axis by intensive insulin therapy during protracted critical illness. J Clin Endocrinol Metab 2004; 89: 3105-3113
22. Jonghe B De, Sharshar T, Lefaucheur JP et al. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA 2002; 288: 2859-2867
23. Annane D, Sébille V, Charpentier C et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871
24. Bolton CF. Electrophysiologic studies of critically ill patients. Muscle Nerve 1987; 10: 129-135
25. Schwarz J, Planck J, Briegel J et al. Single-fiber electromyography, nerve conduction studies, and conventional electromyography in patients with critical-illness polyneuropathy: evidence for a lesion of terminal motor axons. Muscle Nerve 1997; 20: 696-701
26. Tennilä A, Salmi T, Pettilä V et al. Early signs of critical illness polyneuropathy in 1CU patients with systemic inflammatory response syndrome or sepsis. Intensive Care Med 2000; 26: 1360-1363
27. Maher J, Rutledge F, Remtulla H et al. Neuromuscular disorders associated with failure to wean from the ventilator. Intensive Care Med 1995; 21: 737-743
28. Wheeler AP, Bernard GR. Treating patients with severe sepsis. N Engl J Med 1999; 340: 207-214
29. Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia JL et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med 2001; 27: 1288-1296
30. Thiele RI, Jakob H, Hund E et al. Sepsis and catecholamine support are the major risk factors for critical illness polyneuropathy after open heart surgery. Thorac Cardiovasc Surg 2000; 48: 145-150
31. Zifko UA. Long-term outcome of critical illness polyneuropathy. Muscle Nerve 2000; Suppl 9: S49-S52
32. Fletcher SN, Kennedy DD, Ghosh IR et al. Persistent neuromuscular and neurophysiologic abnormalities in long-term survivors of prolonged critical illness. Crit Care Med 2003; 31: 1012-1016
33. Herridge MS, Cheung AM, Tansey CM et al. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med 2003; 348: 683-693
34. Sèze M De, Petit H, Wiart L et al. Critical illness polyneuropathy. A 2-year follow-up study in 19 severe cases. Eur Neurol 2000; 43: 61-69
35. Leijten FSS, Harinck-de Weerd JE, Poortvliet DCJ et al. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA 1995; 274: 1221-1225
36. Schaaf M van der, Beelen A, Vos R de. Functional outcome in patients with critical illness polyneuropathy. Disabil Rehabil 2004; 26: 1189-1197
37. Bogdanski R, Blobner M, Werner C. Critical illness polyneuropathy and myopathy: do they persist for lifetime? Crit Care Med 2003; 31: 1279-1280
38. Hund E, Abel R. Spinaler Schock. Intensiv- und Notfallbehandlung 2002; 27: 131-136
39. Hughes RAC, Bihari D. Acute neuromuscular respiratory paralysis. J Neurol Neurosurg Psychiatry 1993; 56: 334-343
40. Lacomis D, Petrella JT, Giuliani MJ. Causes of neuromuscular weakness in the intensive care unit: a study of ninety-two patients. Muscle Nerve 1998; 21: 610-617
41. Hund E. Critical illness-Polyneuropathie und -Myopathie. Intensivmed Notfallmed 2003; 40: 203-211
42. Geller TJ, Kaiboriboon K, Fenton GA et al. Vecuronium-associated axonal motor neuropathy: a variant of critical illness polyneuropathy? Neuromuscul Disord 2001; 11: 579-582
43. Pamphlett R, Walsh J. Infective endocarditis with inflammatory lesions in the peripheral nervous system. Acta Neuropathol 1989; 78: 101-104
44. Windebank AJ. Chemotherapeutic neuropathy. Curr Opin Neurol 1999; 12: 565-571
45. Schattschneider J, Wasner G, Baron R. Zytostatikainduzierte Polyneuropathien. Akt Neurol 2001; 28: 53-61
46. Latronico N. Neuromuscular alterations in the critically ill patient: critical illness myopathy, critical illness neuropathy, or both? Intensive Care Med 2003; 29: 1411-1413
47. Hund E. Myopathy in critically ill patients. Crit Care Med 1999; 27: 2544-2547
48. Lewis KS, Rothenberg DM. Neuromuscular blockade in the intensive care unit. Am J Health Syst Pharm 1999; 56: 72-75
49. Sander HW, Golden M, Danon MJ. Quadriplegic areflexic ICU illness: selective thick filament loss and normal nerve histology. Muscle Nerve 2002; 26: 499-505
50. Lacomis D, Zochodne DW, Bird SJ. Critical illness myopathy. Muscle Nerve 2000; 23: 1785-1788
51. Rich MM, Bird SJ, Raps EC et al. Direct muscle stimulation in acute quadriplegic myopathy. Muscle Nerve 1997; 20: 665-673
52. Bednarik J, Lukas Z, Vondracek P. Critical illness polyneuromyopathy: the electrophysiological components of a complex entity. Intensive Care Med 2003; 29: 1505-1514
53. Segredo V, Caldwell JE, Matthay MA et al. Persistent paralysis in critically ill patients after long-term administration of vecuronium. N Engl J Med 1992; 327: 524-528
54. Blobner M, Kochs E, Fink H et al. Pharmacokinetics and pharmacodynamics of vecuronium in rats with systemic inflammatory response syndrome: treatment with NG-monomethyl-L-arginine. Anesthesiology 1999; 91: 999-1005
55. Fuchs-Buder T. Neuromuskuläres Monitoring. Eine Standortbestimmung. Anaesthesist 1998; 47: 629-637
56. Dunsire MF, Clarke SG, Stedmon JJ. Undiagnosed myasthenia gravis unmasked by neuromuscular blockade. Br J Anaesth 2001; 86: 727-730
57. Cherington M. Clinical spectrum of botulism. Muscle Nerve 1998; 21: 701-710
58. Reinhart K, Brunkhorst FM, Bloos F. Fortschritte in der Therapie der Sepsis. Dtsch Ärztebl 2003; 100: A2080-2086
59. Mohr M, Englisch L, Roth A et al. Effects of early treatment with immunoglobulin on critical illness polyneuropathy following multiple organ failure and gram-negative sepsis. Intensive Care Med 1997; 23: 1144-1149